Several companies are currently undergoing their initial public offerings, including EXTREME VISION (06636), EPIWORLD (02726), TONGSHIFU (00664), HUAYAN ROBOTICS (01021), TONGRENTANGCARE (02667), DIAGENS-B (02526), and FOURSEMI (03625). As of March 24, brokerages such as Futu Securities and Tiger Brokers have provided margin financing of HKD 31.72 billion for EXTREME VISION, representing an oversubscription of over 1,270.84 times. For EPIWORLD, HKD 2.86 billion was lent, with an oversubscription exceeding 17.45 times. TONGSHIFU received HKD 1.028 billion in financing, oversubscribed by more than 20.41 times. HUAYAN ROBOTICS saw HKD 122.81 billion in margin lending, leading to an oversubscription of over 1,788.41 times. TONGRENTANGCARE attracted HKD 532 million, oversubscribed by over 5.34 times. DIAGENS-B obtained HKD 20.273 billion in financing, resulting in an oversubscription exceeding 225.26 times. FOURSEMI received HKD 4.827 billion, with an oversubscription of over 160.88 times.